Chimerix Non Current Liabilities Total vs Total Liab Analysis

CMRX Stock

USD 0.97 0.01 1.04%

Chimerix financial indicator trend analysis is way more than just evaluating Chimerix prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chimerix is a good investment. Please check the relationship between Chimerix Non Current Liabilities Total and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimerix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.

Non Current Liabilities Total vs Total Liab

Non Current Liabilities Total vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chimerix Non Current Liabilities Total account and Total Liab. At this time, the significance of the direction appears to have no relationship.

The correlation between Chimerix's Non Current Liabilities Total and Total Liab is 0.06. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Liab in the same time period over historical financial statements of Chimerix, assuming nothing else is changed. The correlation between historical values of Chimerix's Non Current Liabilities Total and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Chimerix are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Non Current Liabilities Total i.e., Chimerix's Non Current Liabilities Total and Total Liab go up and down completely randomly.

Correlation Coefficient

0.06

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Non Current Liabilities Total

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Chimerix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chimerix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimerix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.Sales General And Administrative To Revenue is likely to rise to 79.73 in 2024, whereas Selling General Administrative is likely to drop slightly above 20.2 M in 2024.

	2021	2022	2023	2024 (projected)
Net Interest Income	164K	2.9M	11.1M	11.6M
Interest Income	164K	2.9M	11.1M	11.6M

Net Interest Income Interest Income

Chimerix fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.42	-0.1	0.94	0.71	0.4	-0.7	0.67	0.16	-0.93	-0.15	-0.18	0.17	0.57	0.27	-0.62	0.49	-0.45	0.98	0.62	-0.65	-0.13	0.82	0.41	0.36	0.5
Total Assets	0.42		-0.46	0.54	0.48	1.0	-0.68	0.57	-0.33	-0.25	0.61	0.26	0.84	0.42	-0.15	-0.58	0.96	-0.25	0.44	0.91	-0.79	-0.48	0.68	0.06	0.34	0.97
Short Long Term Debt Total	-0.1	-0.46		-0.18	0.28	-0.5	0.29	-0.22	0.12	0.07	-0.36	0.03	-0.39	-0.17	-0.1	0.61	-0.44	-0.34	-0.04	-0.5	0.45	0.75	-0.22	0.6	-0.32	-0.45
Other Current Liab	0.94	0.54	-0.18		0.77	0.51	-0.63	0.62	0.22	-0.82	0.06	-0.24	0.35	0.67	0.1	-0.62	0.55	-0.28	0.91	0.72	-0.61	-0.17	0.92	0.51	0.33	0.57
Total Current Liabilities	0.71	0.48	0.28	0.77		0.44	-0.53	0.53	0.08	-0.59	0.27	-0.04	0.38	0.43	-0.15	-0.44	0.47	-0.37	0.71	0.53	-0.49	0.24	0.72	0.84	0.14	0.48
Total Stockholder Equity	0.4	1.0	-0.5	0.51	0.44		-0.68	0.56	-0.34	-0.24	0.6	0.28	0.84	0.4	-0.14	-0.58	0.97	-0.25	0.42	0.91	-0.79	-0.51	0.65	0.01	0.34	0.97
Other Liab	-0.7	-0.68	0.29	-0.63	-0.53	-0.68		-0.62	0.4	0.68	-0.11	-0.36	-0.37	-0.35	-0.19	0.75	-0.75	0.61	-0.72	-0.62	0.93	0.14	-0.58	-0.03	-0.36	-0.75
Property Plant And Equipment Net	0.67	0.57	-0.22	0.62	0.53	0.56	-0.62		0.16	-0.63	0.25	-0.19	0.54	0.2	0.43	-0.64	0.52	-0.22	0.62	0.66	-0.63	-0.25	0.63	0.22	0.36	0.53
Net Debt	0.16	-0.33	0.12	0.22	0.08	-0.34	0.4	0.16		-0.23	-0.12	-0.99	-0.02	0.06	-0.04	0.13	-0.46	0.49	0.09	0.01	0.34	0.03	0.18	0.31	0.06	-0.44
Retained Earnings	-0.93	-0.25	0.07	-0.82	-0.59	-0.24	0.68	-0.63	-0.23		0.28	0.23	0.0	-0.53	-0.34	0.6	-0.33	0.48	-0.91	-0.47	0.62	0.12	-0.65	-0.3	-0.46	-0.34
Accounts Payable	-0.15	0.61	-0.36	0.06	0.27	0.6	-0.11	0.25	-0.12	0.28		0.06	0.77	-0.08	-0.34	-0.3	0.46	0.32	-0.16	0.47	-0.28	-0.25	0.24	0.13	0.04	0.47
Cash	-0.18	0.26	0.03	-0.24	-0.04	0.28	-0.36	-0.19	-0.99	0.23	0.06		-0.04	-0.07	0.02	-0.05	0.4	-0.55	-0.09	-0.08	-0.28	0.07	-0.21	-0.23	-0.09	0.38
Non Current Assets Total	0.17	0.84	-0.39	0.35	0.38	0.84	-0.37	0.54	-0.02	0.0	0.77	-0.04		0.18	-0.16	-0.39	0.67	0.09	0.16	0.76	-0.51	-0.41	0.54	0.11	0.21	0.68
Non Currrent Assets Other	0.57	0.42	-0.17	0.67	0.43	0.4	-0.35	0.2	0.06	-0.53	-0.08	-0.07	0.18		0.02	-0.32	0.46	-0.19	0.58	0.51	-0.29	-0.32	0.64	0.33	0.65	0.47
Other Assets	0.27	-0.15	-0.1	0.1	-0.15	-0.14	-0.19	0.43	-0.04	-0.34	-0.34	0.02	-0.16	0.02		-0.16	-0.13	-0.25	0.25	-0.15	-0.06	-0.22	0.03	-0.2	0.24	-0.13
Long Term Debt	-0.62	-0.58	0.61	-0.62	-0.44	-0.58	0.75	-0.64	0.13	0.6	-0.3	-0.05	-0.39	-0.32	-0.16		-0.6	0.04	-0.55	-0.62	0.79	0.3	-0.54	-0.01	-0.37	-0.6
Cash And Short Term Investments	0.49	0.96	-0.44	0.55	0.47	0.97	-0.75	0.52	-0.46	-0.33	0.46	0.4	0.67	0.46	-0.13	-0.6		-0.4	0.52	0.88	-0.84	-0.46	0.65	0.01	0.35	1.0
Net Receivables	-0.45	-0.25	-0.34	-0.28	-0.37	-0.25	0.61	-0.22	0.49	0.48	0.32	-0.55	0.09	-0.19	-0.25	0.04	-0.4		-0.55	-0.15	0.49	-0.06	-0.24	-0.12	-0.1	-0.39
Common Stock Total Equity	0.98	0.44	-0.04	0.91	0.71	0.42	-0.72	0.62	0.09	-0.91	-0.16	-0.09	0.16	0.58	0.25	-0.55	0.52	-0.55		0.61	-0.67	-0.13	0.78	0.39	0.39	0.53
Short Term Investments	0.62	0.91	-0.5	0.72	0.53	0.91	-0.62	0.66	0.01	-0.47	0.47	-0.08	0.76	0.51	-0.15	-0.62	0.88	-0.15	0.61		-0.77	-0.54	0.82	0.13	0.4	0.89
Non Current Liabilities Total	-0.65	-0.79	0.45	-0.61	-0.49	-0.79	0.93	-0.63	0.34	0.62	-0.28	-0.28	-0.51	-0.29	-0.06	0.79	-0.84	0.49	-0.67	-0.77		0.37	-0.59	0.06	-0.36	-0.84
Inventory	-0.13	-0.48	0.75	-0.17	0.24	-0.51	0.14	-0.25	0.03	0.12	-0.25	0.07	-0.41	-0.32	-0.22	0.3	-0.46	-0.06	-0.13	-0.54	0.37		-0.29	0.5	-0.44	-0.46
Other Current Assets	0.82	0.68	-0.22	0.92	0.72	0.65	-0.58	0.63	0.18	-0.65	0.24	-0.21	0.54	0.64	0.03	-0.54	0.65	-0.24	0.78	0.82	-0.59	-0.29		0.46	0.22	0.67
Total Liab	0.41	0.06	0.6	0.51	0.84	0.01	-0.03	0.22	0.31	-0.3	0.13	-0.23	0.11	0.33	-0.2	-0.01	0.01	-0.12	0.39	0.13	0.06	0.5	0.46		-0.04	0.03
Property Plant And Equipment Gross	0.36	0.34	-0.32	0.33	0.14	0.34	-0.36	0.36	0.06	-0.46	0.04	-0.09	0.21	0.65	0.24	-0.37	0.35	-0.1	0.39	0.4	-0.36	-0.44	0.22	-0.04		0.35
Total Current Assets	0.5	0.97	-0.45	0.57	0.48	0.97	-0.75	0.53	-0.44	-0.34	0.47	0.38	0.68	0.47	-0.13	-0.6	1.0	-0.39	0.53	0.89	-0.84	-0.46	0.67	0.03	0.35

Click cells to compare fundamentals

Chimerix Account Relationship Matchups

Chimerix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	55.5M	62.2M	84.9M	88.8M	88.6M	50.8M
Total Assets	119.4M	84.7M	100.5M	279.3M	212.8M	197.0M
Short Long Term Debt Total	196K	2.8M	16.4M	2.1M	2.1M	3.7M
Other Current Liab	6.8M	7.3M	13.1M	17.4M	14.8M	8.8M
Total Current Liabilities	9.2M	8.5M	29.9M	20.4M	18.4M	15.6M
Total Stockholder Equity	110.0M	73.4M	68.3M	256.9M	193.0M	178.5M
Property Plant And Equipment Net	1.2M	3.0M	2.7M	2.2M	1.7M	1.9M
Net Debt	(16.7M)	(44.2M)	995K	(23.8M)	(25.5M)	(26.8M)
Retained Earnings	(668.8M)	(712.4M)	(885.6M)	(713.4M)	(795.5M)	(755.7M)
Accounts Payable	2.4M	1.3M	2.8M	3.0M	2.9M	3.0M
Cash	16.9M	47.0M	15.4M	25.8M	27.7M	35.5M
Non Current Assets Total	1.3M	3.1M	4.7M	51.2M	23.8M	24.5M
Non Currrent Assets Other	34K	26K	56K	386K	401K	421.1K
Other Assets	34K	2.9M	56K	386K	443.9K	354.3K
Cash And Short Term Investments	113.5M	79.0M	88.4M	217.3M	182.8M	157.8M
Net Receivables	1.2M	340K	348K	1.0M	1.1M	951.9K
Common Stock Total Equity	62K	63K	87K	88K	101.2K	52.8K
Short Term Investments	96.6M	32.0M	73.0M	191.5M	155.2M	109.0M
Liabilities And Stockholders Equity	119.4M	84.7M	100.5M	279.3M	212.8M	197.0M
Non Current Liabilities Total	196K	2.8M	2.4M	2.1M	1.3M	2.1M
Other Current Assets	3.4M	2.4M	4.7M	9.8M	5.0M	3.7M
Total Liab	9.4M	11.3M	32.3M	22.5M	19.7M	18.5M
Property Plant And Equipment Gross	1.2M	3.0M	253K	227K	6.9M	7.2M
Total Current Assets	118.1M	81.7M	95.8M	228.1M	189.0M	163.4M
Common Stock	62K	63K	87K	88K	89K	56.3K
Property Plant Equipment	540K	214K	2.7M	227K	261.1K	248.0K
Other Stockholder Equity	778.7M	785.7M	953.8M	970.5M	988.5M	748.2M
Net Tangible Assets	110.0M	73.4M	68.3M	256.9M	231.2M	151.4M
Retained Earnings Total Equity	(668.8M)	(712.4M)	(885.6M)	(713.4M)	(642.1M)	(674.2M)
Capital Surpluse	778.7M	785.7M	953.8M	970.5M	1.1B	801.9M
Non Current Liabilities Other	144K	196K	2.8M	2.4M	2.8M	2.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
BAC	Bank of America
GM	General Motors

When determining whether Chimerix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chimerix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chimerix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chimerix Stock:

How To Invest In Chimerix

Details

Is Chimerix Stock a good investment?

Details

What is Chimerix's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimerix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.

You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Chimerix Stock analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Commodity Directory Find actively traded commodities issued by global exchanges
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

Is Chimerix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chimerix. If investors know Chimerix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chimerix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.94)

Quarterly Revenue Growth

(0.99)

Return On Assets

(0.26)

Return On Equity

(0.40)

The market value of Chimerix is measured differently than its book value, which is the value of Chimerix that is recorded on the company's balance sheet. Investors also form their own opinion of Chimerix's value that differs from its market value or its book value, called intrinsic value, which is Chimerix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chimerix's market value can be influenced by many factors that don't directly affect Chimerix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chimerix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chimerix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chimerix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chimerix Non Current Liabilities Total vs Total Liab Analysis

Non Current Liabilities Total vs Total Liab

Non Current Liabilities Total vs Total Liab Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Total Liab

Chimerix fundamental ratios Correlations

Chimerix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chimerix fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Chimerix Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock Total Equity	+ 0.98	Common Stock Shares Outstanding
Total Current Assets	+ 0.97	Total Assets
Cash And Short Term Investments	+ 0.97	Total Stockholder Equity
Total Current Assets	+ 0.97	Total Stockholder Equity

Cash	- 0.99	Net Debt
Retained Earnings	- 0.93	Common Stock Shares Outstanding
Common Stock Total Equity	- 0.91	Retained Earnings
Total Current Assets	- 0.84	Non Current Liabilities Total
Non Current Liabilities Total	- 0.84	Cash And Short Term Investments
Retained Earnings	- 0.82	Other Current Liab